跳至主要内容
临床试验/EUCTR2012-003312-30-FR
EUCTR2012-003312-30-FR进行中(未招募)不适用

Interest of preemptive treatment with ganciclovir or acyclovir in patients requiring prolonged mechanical ventilation and have either a cytomegalovirus replication in blood or an herpes simplex virus oropharyngeal replication: Prospective, multicenter, randomized double-blind

ASSISTANCE PUBLIQUE HOPITAUX DE MARSEILLE0 个研究点开始时间: 2013年6月25日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • - Invasive mechanical ventilation for 96 hours at least and duration of predictable mechanical ventilation of at least 48 am more
  • - Positive PCR (see below the criteria of positivity of this PCR)
  • - An age of at least 18 years
  • - The obtaining of the written consent of the patient of one of his(her) close relations or the beforehand indicated reliable person.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 264
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 216

排除标准

  • Old Patients under age 18
  • - Patient receiving from the ganciclovir or from the aciclovir
  • - Use by general way of the others antiviral active on the CMV and/or the HSV during the previous month the inclusion (cidofovir, foscarnet, to ganciclovir, yet(now) to to valacyclovir)
  • - Infection to CMV or to HSV treated(handled) by general way during the previous month the admission in resuscitation
  • - Sentimentality in the ganciclovir for the arm CMV or in the aciclovir for the arm HSV
  • - Pregnancy
  • - Patients hospitalized for a medullary aplasie
  • - Patients transplanted by solid organs or by marrow
  • - Expanding Patients of the HIV
  • - Treatment to immunosupresseur

研究者

相似试验